BioSpace News Archive

Transparency Market Research has published a new report on the global collagen and HA-based biomaterials market for the forecast period of 2019–2027.

Transparency Market Research has published a new report titled, “Canes and Crutches Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”.

Pure, homogenous and stable chemicals, analytical standards are responsible for precision in quantitative analysis and thus, they are used in examination of analytical method performance and calibration of apparatus.

Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced the opening of its new walk-in COVID-19 test facility at Hamburg Airport.

OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that that Dr. Napoleone Ferrara, MD, Professor at the University of California San Diego Medical Center, has agreed to serve on its scientific advisory board.

Anavex Life Sciences Corp. announced that the Shake It Up Foundation for Parkinson’s Research and its international partners has committed to invest into Anavex up to 50% of the costs of a disease modifying clinical study to develop ANAVEX®2-73 for the disease modifying treatment of Parkinson’s disease.

The Study of KEDRAB®(Rabies Immune Globulin [Human]) Conducted in Children was the First and Only Pediatric Study for any HRIG Available in U.S.

Initiated Phase 3 SHIELD I Trial for D-PLEX100 in Abdominal Surgery and Received Fast Track Designation for D-PLEX100from FDA

Apexigen, Inc. announced the appointment of Jakob Dupont, M.D., to its Board of Directors.

Alkermes plc announced the initiation of ARTISTRY-3, a new phase 2 study to evaluate the clinical and immunologic effects of ALKS 4230 monotherapy on the tumor microenvironment of a variety of advanced, malignant solid tumors.